U.S. Department of Health and Human Services Office of Disease Prevention and Health Promotion

Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices

About this resource:

HHS Non-systematic Review

Source: Centers for Disease Control and Prevention

Last Reviewed: March 2015

Workgroups: Immunization and Infectious Diseases Workgroup

The Advisory Committee on Immunization Practices (ACIP) recommends the Gardasil 9 vaccine as one of 3 vaccines to be used to prevent HPV (human papillomavirus). ACIP recommends HPV vaccination for groups including:

  • Children ages 11 or 12 years 
  • Females ages 13 to 26 years and males ages 13 to 21 years who haven’t been vaccinated before
  • Other high-risk populations who haven’t been vaccinated
Read more about this resource

Objectives related to this resource (1)

Reduce infections of HPV types prevented by the vaccine in young adults — IID‑07
Baseline only

Suggested Citation

1.

Petrosky, E., Bocchini, J.A., Hariri, S., Chesson, H., Curtis, R., Saraiya, M.,...Markowitz, L.E. (2015). Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices. Retrieved from https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6411a3.htm